ISU CHEMICAL CO.,LTD
Financials
Valuation Metrics
ISU CHEMICAL CO.,LTD's Market Cap is ₩3576B. At end of 2025 it was ₩2172B. Ranked #563 of 2,436 in KR market (top 23%), #342 of 787 on KOSPI (top 43%), #66 of 294 in Materials (top 22%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 357.60B KRW | KR#563/2,436 Sec#66/294 |
| Revenue | 1.89T KRW | KR#258/2,436 Sec#32/294 |
| Net Income | -5.86B KRW | KR—/2,436 Sec—/294 |
| Total Assets | 1.03T KRW | KR#461/2,436 Sec#69/294 |
| Net Assets | 391.52B KRW | KR#585/2,436 Sec#94/294 |
| Employees | 307 | KR#768/2,436 Sec#88/294 |
| Value | ||
| P/B | 0.91x | KR#1,408/2,436 Sec#226/294 |
| P/S | 0.19x | KR#336/2,436 Sec#53/294 |
| EV/EBITDA | 8.27x | KR#484/2,436 Sec#49/294 |
| FCF Yield | -6.95% | KR—/2,436 Sec—/294 |
| Profitability | ||
| ROE | -1.50% | KR#1,590/2,436 Sec#213/294 |
| ROA | -0.57% | KR#1,561/2,436 Sec#208/294 |
| Op. Margin | 1.70% | KR#1,395/2,436 Sec#167/294 |
| Revenue Growth | 58.72% | KR#242/2,436 Sec#10/294 |
| Financial Health | ||
| Debt Ratio | 264.20% | KR#2,044/2,436 Sec#269/294 |
| Total Debt | 55.73B KRW | KR#939/2,436 Sec#155/294 |
| FCF | -24.85B KRW | KR#1,953/2,436 Sec#236/294 |
| Cash | 146.23B KRW | KR#348/2,436 Sec#42/294 |
| Current Ratio | 1.13x | KR#1,675/2,436 Sec#203/294 |
| Net Debt/EBITDA | -2.80x | KR#215/2,436 Sec#22/294 |
| Dividend | ||
| Div. Yield | 4.26% | KR#463/2,436 Sec#80/294 |
| Div. Growth | 0.00% | KR—/2,436 Sec—/294 |
| Performance | ||
| 1Y Return | 128.96% | KR#89/2,436 Sec#6/294 |
| 1M Return | -3.68% | KR#1,276/2,436 Sec#160/294 |
| From 52W High | -24.40% | KR#250/2,436 Sec#38/294 |
| 1Y MDD | -42.30% | KR#605/2,436 Sec#91/294 |
| Trading | ||
| Volume | 780,665 shares | KR#170/2,436 Sec#12/294 |
| Foreign Own. | 7.71% | KR#577/2,436 Sec#53/294 |
| Per Share | ||
| EPS | -94 KRW | KR—/2,436 Sec—/294 |
| BPS | 4,425 KRW | KR#1,544/2,436 Sec#212/294 |
Company Info
Headquartered in Seocho-gu, Seoul, Isu Chemical was established in 1969, engaging in petrochemical product manufacturing, subsidiary construction, and biopharmaceutical businesses. Its petrochemical division produces synthetic detergent raw materials such as LAB, NP, and LAS, while the construction division operates as a general construction company under the Brownstone apartment brand. The pharmaceutical division markets various biosimilar medicines and is pursuing the commercialization of high value-added products and an overseas smart farm export model.